Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Fosamax

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 24 USDMF, 13 CEP/COS, 6 JDMF, 12 EU WC, 4 KDMF, 10 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

268 FDF Dossiers, 64 FDA Orange Book, 137 Europe, 23 Canada, 14 Australia, 3 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 70MG BASE, TABLET;ORAL - EQ 70MG BASE;2,800 IU, TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 18 SPI Pharma, 6 DKSH, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 2 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 1 Bioplus Life Sciences, 7 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures, 5 Ingredion Pharma Solutions, 15 Kerry, 3 Keval Exports, 3 Lonza Capsugel, 12 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 18 Roquette, 1 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 33 Direct Compression, 29 Disintegrants & Superdisintegrants, 24 Granulation, 24 Taste Masking, 19 Thickeners and Stabilizers, 17 Chewable & Orodispersible Aids, 14 Lubricants & Glidants, 14 Co-Processed Excipients, 8 Parenteral, 8 Empty Capsules, 6 Coating Systems & Additives, 4 Controlled & Modified Release, 3 API Stability Enhancers, 3 Solubilizers, 3 Emulsifying Agents, 2 Topical, 2 Rheology Modifiers, 1 Film Formers & Plasticizers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 25 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 77 Regulatory FDF Prices

MARKET PLACE

10 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 JP, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Polpharma	Poland	PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski PL	R1-CEP 2003-273 - Rev 04	Sodium alendronate trihydrate	2021-05-12	Valid	Chemical		1564
29/11/2025	Sanofi	France	SANOFI İLAÇ SANAYI VE TICARET A.Ş. Istanbul TR	R1-CEP 2004-215 - Rev 04	Sodium alendronate trihydrate	2019-01-04	Valid	Chemical		1564

Fosamax

Fosamax

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

55 API Suppliers

24 USDMF

13 CEP/COS

6 JDMF

12 EU WC

4 KDMF

10 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

268 FDF Dossiers

64 FDA Orange Book

137 Europe

23 Canada

14 Australia

3 South Africa

27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 70MG BASE

TABLET;ORAL - EQ 70MG BASE;2,800 IU

TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc

18 SPI Pharma

6 DKSH

1 Pharm-RX Chemical

3 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Pfanstiehl

3 Kirsch Pharma

4 ACG Worldwide

2 Actylis

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 BASF

1 Bioplus Life Sciences

7 DFE Pharma

5 Gangwal Chemicals

1 Ideal Cures

5 Ingredion Pharma Solutions

15 Kerry

3 Keval Exports

3 Lonza Capsugel

12 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qualicaps

18 Roquette

1 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

4 Silverline Chemicals

1 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders

33 Direct Compression

29 Disintegrants & Superdisintegrants

24 Granulation

24 Taste Masking

19 Thickeners and Stabilizers

17 Chewable & Orodispersible Aids

14 Lubricants & Glidants

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 35MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons